Gene · 2176
Papers2,586
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,586
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [Chinese expert consensus on the diagnosis and treatment of Fanconi anemia (version 2022)]. | Zhonghua Yi Xue Za Zhi | 2023 | 36660784 | PubTator, text mining | PubMed |
| The role of autophagy in viral infections. | J Biomed Sci | 2023 | 36653801 | PubTator, text mining | PubMed |
| Cross-ancestry genome-wide analysis of atrial fibrillation unveils disease biology and enables cardioembolic risk prediction. | Nat Genet | 2023 | 36653681 | PubTator, text mining | PubMed |
| Actionable genomic landscapes from a real-world cohort of urothelial carcinoma patients. | Urol Oncol | 2023 | 36653279 | PubTator, text mining | PubMed |
| The FANCC-FANCE-FANCF complex is evolutionarily conserved and regulates meiotic recombination. | Nucleic Acids Res | 2023 | 36652992 | PubTator, text mining | PubMed |
| PMS2 Pathogenic Variant in Lynch Syndrome-Associated Colorectal Cancer with Polyps. | Glob Med Genet | 2023 | 36644715 | PubTator, text mining | PubMed |
| Mutational signature of extracranial meningioma metastases and their respective primary tumors. | Acta Neuropathol Commun | 2023 | 36641486 | PubTator, text mining | PubMed |
| Genome-wide siRNA screens identify RBBP9 function as a potential target in Fanconi anaemia-deficient head-and-neck squamous cell carcinoma. | Commun Biol | 2023 | 36639418 | PubTator, text mining | PubMed |
| Profiling of the genetic features of Chinese patients with gastric cancer with HRD germline mutations in a large-scale retrospective study. | J Med Genet | 2023 | 36627197 | PubTator, text mining | PubMed |
Whole-exome sequencing identifies FANC heterozygous germline mutation as an adverse factor for immunosuppressive therapy in Chinese aplastic anemia patients aged 40 or younger: a single-center retrospective study. | Ann Hematol | 2023 | 36622392 | PubTator, text mining | PubMed |
| Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers. | Nat Commun | 2023 | 36611031 | PubTator, text mining | PubMed |
| The molecular athlete: exercise physiology from mechanisms to medals. | Physiol Rev | 2023 | 36603158 | PubTator, text mining | PubMed |
| The clinical utility of integrative genomics in childhood cancer extends beyond targetable mutations. | Nat Cancer | 2023 | 36585449 | PubTator, text mining | PubMed |
| PD-1 inhibitor plus anlotinib for metastatic castration-resistant prostate cancer: a real-world study. | Asian J Androl | 2023 | 36537376 | PubTator, text mining | PubMed |
| Cannabidiol-induced transcriptomic changes and cellular senescence in human Sertoli cells. | Toxicol Sci | 2023 | 36519830 | PubTator, text mining | PubMed |
| Characterization of the Escherichia coli XPD/Rad3 iron-sulfur helicase YoaA in complex with the DNA polymerase III clamp loader subunit chi (χ). | J Biol Chem | 2023 | 36509145 | PubTator, text mining | PubMed |
| High molecular diagnostic yields and novel phenotypic expansions involving syndromic anorectal malformations. | Eur J Hum Genet | 2023 | 36474027 | PubTator, text mining | PubMed |
| Antecedent, behaviour, and consequence (a-b-c) of deploying the contact tracing app in response to COVID-19: Evidence from Europe. | Technol Forecast Soc Change | 2023 | 36439939 | PubTator, text mining | PubMed |
| Return of individual genomic research results within the PRAEGNANT multicenter registry study. | Breast Cancer Res Treat | 2023 | 36409394 | PubTator, text mining | PubMed |
| Nuclear pCHK1 as a potential biomarker of increased sensitivity to ATR inhibition. | J Pathol | 2023 | 36373784 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2176/papers?page=17